708 On Other Exchanges
Symbol
Exchange
Hong Kong
Frankfurt

evergrande health industry g (708) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for EVERGRANDE HEALTH INDUSTRY G (708)
\

Related News

No related news articles were found.

evergrande health industry g (708) Related Businessweek News

No Related Businessweek News Found

evergrande health industry g (708) Details

Evergrande Health Industry Group Limited, an investment holding company, operates as a health management company in the People’s Republic of China. It develops and sells health and living properties; and provides community health management, medical cosmetology, and anti-aging services. The company is involved in the wholesale of home care and healthcare products; and cosmetic products, as well as provision of hospital management, and software and advertisement design services. In addition, it offers information technology consultancy services. The company was formerly known as New Media Group Holdings Limited and changed its name to Evergrande Health Industry Group Limited in April 2015. Evergrande Health Industry Group Limited was founded in 1999 and is headquartered in Guangzhou, China. Evergrande Health Industry Group Limited is a subsidiary of China Evergrande Group.

907 Employees
Last Reported Date: 09/29/15
Founded in 1999

evergrande health industry g (708) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: CNY4.7M
Chairman
Total Annual Compensation: CNY115.0K
Vice Chairman
Total Annual Compensation: CNY69.0K
Executive Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2018.
evergrande health industry g
Evergrande Health Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2018

Evergrande Health Industry Group Limited announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was CNY 3,133.018 million compared to CNY 1,328.474 million a year ago. Net loss was CNY 1,429.381 million compared to net income of CNY 307.748 million a year ago.

Evergrande Health Industry Group Limited to Report Fiscal Year 2018 Results on Mar 22, 2019

Evergrande Health Industry Group Limited announced that they will report fiscal year 2018 results on Mar 22, 2019

Evergrande Health Industry Group Limited, Board Meeting, Mar 22, 2019

Evergrande Health Industry Group Limited, Board Meeting, Mar 22, 2019. Agenda: To consider and approve the annual results of the Company and its subsidiaries for the year ended 31 December 2018 for publication.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

708 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 708.
View Industry Companies
 

Industry Analysis

708

Industry Average

Valuation 708 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 12.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EVERGRANDE HEALTH INDUSTRY G, please visit www.evergrandehealth.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.